Driehaus Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.2M Buy
2,304,414
+694,072
+43% +$15.1M 0.32% 109
2025
Q4
$35.4M Buy
+1,610,342
New +$29.1M 0.24% 136
2024
Q4
Sell
-777,590
Closed -$33M 453
2024
Q3
$33M Sell
777,590
-177,654
-19% -$7.53M 0.28% 112
2024
Q2
$38.5M Sell
955,244
-362,193
-27% -$15.1M 0.37% 85
2024
Q1
$46.7M Buy
+1,317,437
New +$35.3M 0.46% 57
2022
Q1
Sell
-42,164
Closed -$6.35M 448
2021
Q4
$6.35M Buy
+42,164
New +$5.69M 0.06% 283
2021
Q1
Sell
-8,950
Closed -$856K 519
2020
Q4
$856K Sell
8,950
-351,720
-98% -$36.2M 0.01% 333
2020
Q3
$40.9M Sell
360,670
-935
-0.3% -$98.2K 0.84% 21
2020
Q2
$35.8M Buy
361,605
+19,824
+6% +$1.58M 0.87% 18
2020
Q1
$22M Buy
341,781
+150,896
+79% +$10.6M 0.73% 30
2019
Q4
$11.4M Sell
190,885
-157,573
-45% -$9.72M 0.3% 94
2019
Q3
$20.6M Sell
348,458
-116,601
-25% -$7.44M 0.67% 33
2019
Q2
$30M Sell
465,059
-18,660
-4% -$1.2M 0.94% 17
2019
Q1
$30.7M Buy
483,719
+133,653
+38% +$7.02M 1.15% 14
2018
Q4
$13.3M Buy
350,066
+138,206
+65% +$4.88M 0.57% 43
2018
Q3
$9.08M Buy
211,860
+166,860
+371% +$5.83M 0.28% 115
2018
Q2
$991K Buy
+45,000
New +$553K 0.03% 345
2016
Q1
Sell
-7,470
Closed -$882K 638
2015
Q4
$882K Buy
+7,470
New +$741K 0.03% 391
2014
Q2
Sell
-4,530
Closed -$1M 623
2014
Q1
$1M Buy
+4,530
New +$1.16M 0.03% 396

Other funds holding TNDM

Driehaus Capital Management's TNDM Position: Q1 2026 in Review

Driehaus Capital Management increased its Tandem Diabetes Care (TNDM) stake by 43% in Q1 2026, buying an estimated $15.1M and bringing the position to 2,304,414 shares worth $44.2M. The position accounts for 0.32% of the portfolio, ranked #109.

Driehaus Capital Management first reported a position in TNDM in Q1 2014 and has held it in 19 quarters since. The position peaked at $46.7M in Q1 2024. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Driehaus Capital Management held 2,304,414 shares of Tandem Diabetes Care worth $44.2M as of Q1 2026.
  • Driehaus Capital Management bought 694,072 Tandem Diabetes Care shares in Q1 2026, an estimated $15.1M.
  • Tandem Diabetes Care made up 0.32% of Driehaus Capital Management's portfolio in Q1 2026, its #109 holding.
  • Driehaus Capital Management first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 19 quarters since.
  • Driehaus Capital Management's Tandem Diabetes Care position peaked at $46.7M in Q1 2024.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.